Press releases

September 29, 2020

DARPA Awards Inflammatix up to $1.1 Million to Develop Diagnostic that Predicts COVID-19 Severity Risk

April 29, 2020

Study Demonstrates Substantial Cost Savings in Health Economic Model of the Inflammatix Host-Response Test for Sepsis

April 16, 2020

Inflammatix Appoints João Fonseca, Ph.D., as Chief Technology Officer

March 18, 2020

Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force

March 4, 2020

New Inflammatix Study in Nature Communications Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System

January 10, 2020

Inflammatix Announces $32 Million in Series C Funding

November 14, 2019

Inflammatix Announces Funding from BARDA to Advance HostDx™ Tests

August 6, 2019

Inflammatix Wins AACC’s Disruptive Technology Award For Its Rapid HostDx™ Tests